Product
imiglucerase
Aliases
Cerezyme, Cerezyme®
Name
Cerezyme
INN Name
IMIGLUCERASE
FDA Approved
Yes
2 clinical trials
1 organization
3 indications
1 document
Indication
Gaucher's Disease Type IIIIndication
Gaucher Disease Type 1Indication
Gaucher Disease Type 3Clinical trial
A Phase 3, Multicenter, Multinational, Randomized, Double-blind, Double-dummy, Active-comparator Study to Evaluate the Efficacy and Safety of Venglustat in Adult and Pediatric Patients With Gaucher Disease Type 3 (GD3) Who Have Reached Therapeutic Goals With Enzyme Replacement Therapy (ERT)Status: Recruiting, Estimated PCD: 2025-09-30
Clinical trial
A 4-part, Open-label, Multicenter, Multinational Study of the Safety, Tolerability, Pharmacokinetics, Pharmacodynamic, and Exploratory Efficacy of Venglustat in Combination With Cerezyme in Adult Patients With Gaucher Disease Type 3 With Venglustat Monotherapy ExtensionStatus: Active (not recruiting), Estimated PCD: 2025-09-30
Document
DailyMed Label: CerezymeOrganization
Genzyme Corporation